1-5 of 5
Marek Wróbel
Close
Sort by
Journal Articles

Comparative Effectiveness of Daratumumab Monotherapy Versus a Real-World Historical Control from the Czech Republic in Heavily Pretreated and Highly Refractory Multiple Myeloma Patients

Roman Hájek, Tomas Jelinek, MD, Vladimir Maisnar, MD PhD, Ludek Pour, Ivan Spicka, MD PhD, Jiri Minarik, MD PhD, Evzen Gregora, MD, Petr Kessler, MD, Michal Sykora, MD, Hana Frankova, MD, Dagmar Adamova, MD, Marek Wróbel, Peter Mikula, MD, Jiri Jarkovsky, MSc, PhD, Xenia Gatopoulou, Sarka Vesela, Joris Diels, PhD, Hervé Besson, PhD, Lucie Brozova, MSc, Tetsuro Ito
Journal: Blood
Blood (2016) 128 (22): 3332.
https://doi.org/10.1182/blood.V128.22.3332.3332
Published: 2016
Journal Articles

Multiple Myeloma R-ISS Prognostic Stratification System in Real Life Population

Jakub Radocha, MD PhD, Vladimír Maisnar, MD PhD, Ludek Pour, MD PhD, Zdenek Adam, MD PhD, Ivan Spicka, MD PhD, Jan Straub, MD, Vlastimil Scudla, prof, MD PhD, Jiri Minarik, MD PhD, Evzen Gregora, MD, Petr Pavlicek, MD, Hana Frankova, MD, Lenka Zahradova, MD PhD, Alexandra Jungova, MD, Michal Sykora, MD, Petr Kessler, MD, Dagmar Adamova, MD, Marek Wrobel, MD, Lenka Sedlarikova, MSc, Sabina Sevcikova, RNDr, PhD, Daniel Horinek, Ing, Jana Pelcova, MSc, Jiri Jarkovsky, MSc, PhD, Roman Hájek
Journal: Blood
Blood (2016) 128 (22): 3333.
https://doi.org/10.1182/blood.V128.22.3333.3333
Published: 2016
Journal Articles

Registry of Monoclonal Gammopathies (RMG) in the Czech Republic

Jakub Radocha, MD PhD, Ludek Pour, MD PhD, Ivan Spicka, MD PhD, Vlastimil Scudla, MD PhD, Evzen Gregora, MD, Hana Frankova, MD, Roman Hajek, MD, Miroslava Schutzova, MD, Michal Sykora, MD, Petr Kessler, MD, Dagmar Adamova, MD, Marek Wrobel, MD, Lenka Sedlarikova, MSc, Sabina Sevcikova, RNDr, PhD, Daniel Horinek, MSc, Jana Pelcova, Bc, Lucie Brozova, Mgr, Jiri Jarkovsky, MSc, PhD, Vladimir Maisnar, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4514.
https://doi.org/10.1182/blood.V126.23.4514.4514
Published: 2015
Journal Articles

Subcutaneous and Intravenous Bortezomib in Multiple Myeloma Patients Has Similar Response Rates and Toxicity Profile with No Difference in the Incidence of Peripheral Neuropathy: Report of the Czech Myeloma Group

Jiri Minarik, MD PhD, Petr Pavlicek, MD, Ludek Pour, Doc, MD PhD, Tomas Pika, MD PhD, Vladimir Maisnar, As Prof, MD PhD, Ivan Spicka, prof, MD PhD, Jiri Jarkovsky, RNDr, PhD, Marta Krejci, As Prof, MD PhD, Jaroslav Bacovsky, MD PhD, Jakub Radocha, MD PhD, Jan Straub, MD, Petr Kessler, MD, Marek Wrobel, MD, Lenka Walterova, MD, Michal Sykora, MD, Jarmila Obernauerova, MD, Evzen Gregora, MD, Dagmar Adamova, MD, Jaromir Gumulec, MD, Zdenek Adam, prof, MD PhD, Vlastimil Scudla, prof, MD PhD, Roman Hajek, Prof, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2117.
https://doi.org/10.1182/blood.V124.21.2117.2117
Published: 2014
Journal Articles

Bortezomib (Velcade) in the Treatment of Relapsed or Refractory Multiple Myeloma: Analysis of Safety and Efficacy of Bortezomib From Registry of Monoclonal Gammopathy of Czech Myeloma Group

Viera Sandecka, MD, Ivan Spicka, As. Prof. MD, PhD, Vladimir Maisnar, As. Prof. MD, PhD, Tomas Pika, MD, PhD, Evzen Gregora, MD, David Starostka, MD, Lenka Walterova, MD, Jaromir Gumulec, MD, Dagmar Adamova, MD, Marek Wrobel, MD, Ivan Vonke, MD, Lenka Zahradova, MD, PhD, Jan Straub, MD, Jakub Radocha, MD, PhD, Jiri Minarik, MD, PhD, Petr Pavlicek, MD, Petr Kessler, MD, Ludek Pour, MD, PhD, Roman Hajek, Prof. MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1872.
https://doi.org/10.1182/blood.V120.21.1872.1872
Published: 2012